Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanna Glasebach

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Journal of Biological Chemistry|November 30, 2019
Multiple distinct pathways lead to hyperubiquitylated insoluble TDP-43 protein independent of its translocation into stress granulesFriederike Hans, Hanna Glasebach, Philipp J Kahle
Frontiers in Medicine|July 18, 2025
A standardizable human-based psoriasis skin model for drug developmentHanna Glasebach, Steffen Rupp, Anke Burger-Kentischer
Frontiers in Medicine|September 25, 2025
Human epidermis models demonstrate mediator role of TLR2 and TLR3 for psoriatic inflammationHanna Glasebach, Lukas Denzinger, Steffen Rupp, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|November 30, 2019
Multiple distinct pathways lead to hyperubiquitylated insoluble TDP-43 protein independent of its translocation into stress granulesFriederike Hans, Hanna Glasebach, Philipp J Kahle
Frontiers in Medicine|July 18, 2025
A standardizable human-based psoriasis skin model for drug developmentHanna Glasebach, Steffen Rupp, Anke Burger-Kentischer
Frontiers in Medicine|September 25, 2025
Human epidermis models demonstrate mediator role of TLR2 and TLR3 for psoriatic inflammationHanna Glasebach, Lukas Denzinger, Steffen Rupp, et al.
Pageof 1